This book is an invaluable source of knowledge on bladder cancer biology, epidemiology, biomarkers, prognostic factors, and clinical presentation and diagnosis. It is also rich with plenty of up-to-date information, in a well-organized and easy to use format, focusing on the treatment of bladder cancer including surgery, chemotherapy, radiation therapy, immunotherapy, and vaccine therapy. These chapters, written by the experts in their fields, include many interesting, demonstrative and colorful pictures, figures, illustrations and tables. Due to its practicality, this book is recommended reading to anyone interested in bladder cancer.

Bladder cancer is an malignant disease affecting many patients worldwide. This book includes chapters related to tumor biology, epidemiology, biomarkers, prognostic factors, clinical presentation and diagnosis of bladder cancer, treatment of bladder cancer including surgery, chemotherapy, radiation therapy, and immunotherapy. I would like to thank all the authors and co-authors who have contributed to this book, as well as the InTech Open Access Publisher team, and particularly Ms.Tajana Jevtic, who has been very helpful as a process manager during the preparation of the book. Hopefully this book will be beneficial and useful for colleagues who are interested in bladder cancer.

Contents

Chapter 1 Bladder Cancer Biology
Chapter 2 Biomarkers of Bladder Cancer in Urine: Evaluation of Diagnostic and Prognostic Significance of Current and Potential Markers
Chapter 3 Epigenetic Biomarkers in Bladder Cancer
Chapter 4 Angiogenesis, Lymphangiogenesis and Lymphovascular Invasion: Prognostic Impact for Bladder Cancer Patients
Chapter 5 Angiogenesis and Lymphangiogenesis in Bladder Cancer
Chapter 6 UHRF1 is a Potential Molecular Marker for Diagnosis and Prognosis of Bladder Cancer
Chapter 7 Epidemiology and Polymorphisms Related to Bladder Cancer in Ecuadorian Individuals
Chapter 8 Clinical Presentation
Chapter 9 Role of HPV in Urothelial Carcinogenesis: Current State of the Problem
Chapter 10 Bladder Cancer and Schistosomiasis: Is There a Difference for the Association?
Chapter 11 Hemocyanins in the Immunotherapy of Superficial Bladder Cancer
Chapter 12 The Potential Role of Chemoprevention in the Management of Non-Muscle Invasive Bladder Urothelial Carcinoma
Chapter 13 The Molecular Basis of Cisplatin Resistance in Bladder Cancer Cells
Chapter 14 Chemotherapy for Metastatic Disease
Chapter 15 Robot-Assisted Radical Cystectomy as a Treatment Modality for Patients with Muscle-Invasive Bladder Cancer
Chapter 16 Robotic-Assisted Laparoscopic Radical Cystoprostatectomy and Intracorporeal Urinary Diversion (Studer Pouch or Ileal Conduit) for Bladder Cancer
Chapter 17 Current Trends in Urinary Diversion in Men
Chapter 18 The H19-IGF2 Role in Bladder Cancer Biology and DNA-Based Therapy
Chapter 19 Animal Models for Basic and Preclinical Research in Bladder Cancer
Chapter 20 Intracellular Arsenic Speciation and Quantification in Human Urothelial and Hepatic Cells
Chapter 21 Chemoprevention and Novel Treatments of Non-Muscle Invasive Bladder Cancer